For decades, a single number has stood as medicine's shorthand for cardiovascular danger — yet a researcher's seven years of living with extreme LDL cholesterol and no arterial plaque invites a quieter, more searching question: are we measuring the right things, or merely the most convenient ones? The debate unfolding between metabolic researchers and Irish cardiologists is less a rupture than a refinement, a slow collective turn toward seeing the patient whole rather than through the narrow aperture of one blood marker. What is at stake is not just clinical protocol but the deeper philosophic